Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Neuropsychiatry Committee of the Group for Advancement of Psychiatry

Articles by Neuropsychiatry Committee of the Group for Advancement of Psychiatry

COVID-19 Brings Anosmia to the Attention of Psychiatrists

ByBarbara Schildkrout, MD,Margo Lauterbach, MD,Lindsey MacGillivray, MD, PhD,Shreya Raj, MD,Neuropsychiatry Committee of the Group for Advancement of Psychiatry

August 19th 2021

Loss of smell can be devastating for patients. How can psychiatrists deal with the associated psychological effects?

Latest Updated Articles

COVID-19 Brings Anosmia to the Attention of Psychiatrists
Published: August 19th 2021 | Updated:

Trending on Psychiatric Times

ADHD Found Connected to Substance Use Disorder, With Sex Prevalence Differences

Today Is World Mental Health Day: How Is Yours?

Recognizing the Neuropsychiatric Symptoms of Huntington Disease

"The Harvest"

Poll: How Can We Individually and Collectively Improve Our Mental Health?

© 2025 MJH Life Sciences^®

All rights reserved.